LINC02636
gene geneOn this page
Summary
LINC02636 (long intergenic non-protein coding RNA 2636, HGNC:54119) is a long non-coding RNA gene on chromosome 10q22.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:54119 |
| Approved symbol | LINC02636 |
| Name | long intergenic non-protein coding RNA 2636 |
| Location | 10q22.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000224222 |
| Ensembl biotype | lncRNA |
| Entrez | 102723350 |
| RNAcentral | URS00026A2156 — lncRNA, 9822 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 lncRNA
ENST00000427247, ENST00000653732, ENST00000655496, ENST00000659203, ENST00000667615
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000427247 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001601346 | 70007457 | 70007669 |
| ENSE00001804261 | 69994626 | 69994854 |
| ENSE00004054238 | 70007755 | 70007875 |
| ENSE00004054239 | 70054090 | 70054209 |
Expression profiles
Bgee: expression breadth ubiquitous, 120 present calls, max score 83.02.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0177 / max 13.5464, expressed in 7 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 109810 | 0.0106 | 5 |
| 109809 | 0.0071 | 3 |
Top tissues by expression
120 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.02 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 73.28 | gold quality |
| right frontal lobe | UBERON:0002810 | 72.55 | gold quality |
| primary visual cortex | UBERON:0002436 | 71.44 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 70.80 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 70.08 | gold quality |
| nucleus accumbens | UBERON:0001882 | 69.97 | gold quality |
| right testis | UBERON:0004534 | 69.88 | gold quality |
| caudate nucleus | UBERON:0001873 | 69.16 | gold quality |
| sural nerve | UBERON:0015488 | 69.08 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 68.55 | gold quality |
| frontal cortex | UBERON:0001870 | 68.46 | gold quality |
| left testis | UBERON:0004533 | 68.42 | gold quality |
| cerebral cortex | UBERON:0000956 | 67.60 | gold quality |
| putamen | UBERON:0001874 | 67.58 | gold quality |
| testis | UBERON:0000473 | 67.57 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 67.48 | gold quality |
| cortical plate | UBERON:0005343 | 66.28 | gold quality |
| brain | UBERON:0000955 | 66.24 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 66.24 | gold quality |
| cerebellar cortex | UBERON:0002129 | 65.80 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 65.74 | gold quality |
| cerebellum | UBERON:0002037 | 65.73 | gold quality |
| prefrontal cortex | UBERON:0000451 | 64.41 | gold quality |
| ventricular zone | UBERON:0003053 | 63.49 | gold quality |
| hypothalamus | UBERON:0001898 | 63.20 | gold quality |
| pituitary gland | UBERON:0000007 | 63.17 | gold quality |
| temporal lobe | UBERON:0001871 | 62.60 | gold quality |
| amygdala | UBERON:0001876 | 62.54 | gold quality |
| ganglionic eminence | UBERON:0004023 | 62.37 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.47 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.